Header Logo

Connection

PETER RICHARDSON to Adult

Back to Details
This is a "connection" page, showing publications PETER RICHARDSON has written about Adult.
PETER RICHARDSON
Connection Strength
0.326
Adult
  1. The extent and determinants of prescribing and adherence with acid-reducing medications: a national claims database study. Am J Gastroenterol. 2009 Sep; 104(9):2161-7.
    View in: PubMed
    Score: 0.017
  2. Atherosclerotic Cardiovascular Disease in Gulf War Veterans in Relation to Deployment Exposures. Cardiovasc Toxicol. 2025 Sep; 25(9):1263-1271.
    View in: PubMed
    Score: 0.013
  3. Case Sampling vs Universal Review for Evaluating Hospital Postoperative Mortality in US Surgical Quality Improvement Programs. JAMA Surg. 2023 12 01; 158(12):1312-1319.
    View in: PubMed
    Score: 0.012
  4. Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial. JAMA. 2021 Nov 02; 326(17):1690-1702.
    View in: PubMed
    Score: 0.010
  5. Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States. J Hepatol. 2022 02; 76(2):294-301.
    View in: PubMed
    Score: 0.010
  6. The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study. BMC Cancer. 2021 Jul 05; 21(1):776.
    View in: PubMed
    Score: 0.010
  7. Relationship Between Perioperative Outcomes Used for Profiling Hospital Noncardiac Surgical Quality. J Surg Res. 2021 08; 264:58-67.
    View in: PubMed
    Score: 0.010
  8. Prevalence, correlates and outcomes of absolute and functional iron deficiency anemia in nondialysis-dependent chronic kidney disease. Nephrol Dial Transplant. 2021 01 01; 36(1):129-136.
    View in: PubMed
    Score: 0.010
  9. JAK inhibition reduces SARS-CoV-2 liver infectivity and modulates inflammatory responses to reduce morbidity and mortality. Sci Adv. 2021 01; 7(1).
    View in: PubMed
    Score: 0.010
  10. Incidence and survival for oropharynx and non-oropharynx head and neck cancers among veterans living with HIV. Cancer Med. 2020 12; 9(24):9326-9335.
    View in: PubMed
    Score: 0.010
  11. Mechanism of baricitinib supports artificial intelligence-predicted testing in COVID-19 patients. EMBO Mol Med. 2020 08 07; 12(8):e12697.
    View in: PubMed
    Score: 0.009
  12. Association between intensity of statin therapy and mortality in persons with chronic kidney disease. Nephrol Dial Transplant. 2020 02 01; 35(2):312-319.
    View in: PubMed
    Score: 0.009
  13. Incidence of AIDS-Related Kaposi Sarcoma in All 50 United States From 2000 to 2014. J Acquir Immune Defic Syndr. 2019 08 01; 81(4):387-394.
    View in: PubMed
    Score: 0.009
  14. Risk and Predictors of Esophageal and Stomach Cancers in HIV-Infected Veterans: A Matched Cohort Study. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):e65-e72.
    View in: PubMed
    Score: 0.009
  15. Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease. Gastroenterology. 2018 12; 155(6):1828-1837.e2.
    View in: PubMed
    Score: 0.008
  16. Hepatitis B Virus Screening and Reactivation in a National VA Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Antagonists. Dig Dis Sci. 2018 06; 63(6):1551-1557.
    View in: PubMed
    Score: 0.008
  17. Role of Age and Race in the Risk of Hepatocellular Carcinoma in Veterans With Hepatitis B Virus Infection. Clin Gastroenterol Hepatol. 2018 02; 16(2):252-259.
    View in: PubMed
    Score: 0.008
  18. Risk factors for oropharynx cancer in a cohort of HIV-infected veterans. Oral Oncol. 2017 05; 68:60-66.
    View in: PubMed
    Score: 0.007
  19. Gastric Acid Suppression Is Associated with an Increased Risk of Adverse Outcomes in Inflammatory Bowel Disease. Digestion. 2017; 95(3):188-193.
    View in: PubMed
    Score: 0.007
  20. Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists. Inflamm Bowel Dis. 2017 02; 23(2):254-260.
    View in: PubMed
    Score: 0.007
  21. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol. 2017 02; 66(2):355-362.
    View in: PubMed
    Score: 0.007
  22. Risk of hepatocellular carcinoma after sustained virological response in Veterans with hepatitis C virus infection. Hepatology. 2016 07; 64(1):130-7.
    View in: PubMed
    Score: 0.007
  23. Association between Time on Protease Inhibitors and the Incidence of Squamous Cell Carcinoma of the Anus among U.S. Male Veterans. PLoS One. 2015; 10(12):e0142966.
    View in: PubMed
    Score: 0.007
  24. Prevalence and predictors of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology. 2013 Aug; 58(2):538-45.
    View in: PubMed
    Score: 0.006
  25. Dual therapy with infliximab and immunomodulator reduces one-year rates of hospitalization and surgery among veterans with inflammatory bowel disease. Clin Gastroenterol Hepatol. 2013 Oct; 11(10):1281-7.
    View in: PubMed
    Score: 0.006
  26. Age at onset of GERD symptoms predicts risk of Barrett's esophagus. Am J Gastroenterol. 2013 Jun; 108(6):915-22.
    View in: PubMed
    Score: 0.006
  27. The incidence and prevalence of inflammatory bowel disease among U.S. veterans: a national cohort study. Inflamm Bowel Dis. 2013 Apr; 19(5):1059-64.
    View in: PubMed
    Score: 0.006
  28. Waist-to-hip ratio, but not body mass index, is associated with an increased risk of Barrett's esophagus in white men. Clin Gastroenterol Hepatol. 2013 Apr; 11(4):373-381.e1.
    View in: PubMed
    Score: 0.006
  29. Patient-centered, comparative effectiveness of esophageal cancer screening: protocol for a comparative effectiveness research study to inform guidelines for evidence-based approach to screening and surveillance endoscopy. BMC Health Serv Res. 2012 Aug 28; 12:288.
    View in: PubMed
    Score: 0.005
  30. Use of administrative data to identify colorectal liver metastasis. J Surg Res. 2012 Jul; 176(1):141-6.
    View in: PubMed
    Score: 0.005
  31. Gaps in the achievement of effectiveness of HCV treatment in national VA practice. J Hepatol. 2012 Feb; 56(2):320-5.
    View in: PubMed
    Score: 0.005
  32. Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis C infection. Dig Dis Sci. 2011 Jun; 56(6):1835-47.
    View in: PubMed
    Score: 0.005
  33. Increasing prevalence of HCC and cirrhosis in patients with chronic hepatitis C virus infection. Gastroenterology. 2011 Apr; 140(4):1182-1188.e1.
    View in: PubMed
    Score: 0.005
  34. Importance of patient, provider, and facility predictors of hepatitis C virus treatment in veterans: a national study. Am J Gastroenterol. 2011 Mar; 106(3):483-91.
    View in: PubMed
    Score: 0.005
  35. Medications (NSAIDs, statins, proton pump inhibitors) and the risk of esophageal adenocarcinoma in patients with Barrett's esophagus. Gastroenterology. 2010 Jun; 138(7):2260-6.
    View in: PubMed
    Score: 0.005
  36. Validation of ICD-9-CM diagnostic codes for inflammatory bowel disease among veterans. Dig Dis Sci. 2010 Sep; 55(9):2592-8.
    View in: PubMed
    Score: 0.004
  37. Hospitalizations for inflammatory bowel disease among US military veterans 1975-2006. Dig Dis Sci. 2009 Aug; 54(8):1740-5.
    View in: PubMed
    Score: 0.004
  38. Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era. J Clin Oncol. 2008 Jan 20; 26(3):474-9.
    View in: PubMed
    Score: 0.004
  39. Prevalence and determinants of histological abnormalities of the gastric cardia in volunteers. Scand J Gastroenterol. 2007 Oct; 42(10):1158-66.
    View in: PubMed
    Score: 0.004
  40. Determinants of gastroesophageal reflux disease in adults with a history of childhood gastroesophageal reflux disease. Clin Gastroenterol Hepatol. 2007 Jun; 5(6):696-701.
    View in: PubMed
    Score: 0.004
  41. The prevalence of suspected Barrett's esophagus in children and adolescents: a multicenter endoscopic study. Gastrointest Endosc. 2006 Nov; 64(5):671-5.
    View in: PubMed
    Score: 0.004
  42. Is there a race-based disparity in the survival of veterans with HIV? J Gen Intern Med. 2006 Jun; 21(6):613-7.
    View in: PubMed
    Score: 0.004
  43. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep. 2005 Nov; 28(11):1405-11.
    View in: PubMed
    Score: 0.003
  44. Fundoplication and the risk of esophageal cancer in gastroesophageal reflux disease: a Veterans Affairs cohort study. Am J Gastroenterol. 2005 May; 100(5):1002-8.
    View in: PubMed
    Score: 0.003
  45. The effect of HIV coinfection on the risk of cirrhosis and hepatocellular carcinoma in U.S. veterans with hepatitis C. Am J Gastroenterol. 2005 Jan; 100(1):56-63.
    View in: PubMed
    Score: 0.003
  46. Cirrhosis and hepatocellular carcinoma in HIV-infected veterans with and without the hepatitis C virus: a cohort study, 1992-2001. Arch Intern Med. 2004 Nov 22; 164(21):2349-54.
    View in: PubMed
    Score: 0.003
  47. Sleep apnea in a high risk population: a study of Veterans Health Administration beneficiaries. Sleep Med. 2004 Jul; 5(4):345-50.
    View in: PubMed
    Score: 0.003
  48. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004 Jun; 126(7):1692-9.
    View in: PubMed
    Score: 0.003
  49. Psychiatric disorders among veterans with hepatitis C infection. Gastroenterology. 2002 Aug; 123(2):476-82.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.